CN104994871B - 针对流感的多价融合蛋白疫苗 - Google Patents
针对流感的多价融合蛋白疫苗 Download PDFInfo
- Publication number
- CN104994871B CN104994871B CN201480008848.7A CN201480008848A CN104994871B CN 104994871 B CN104994871 B CN 104994871B CN 201480008848 A CN201480008848 A CN 201480008848A CN 104994871 B CN104994871 B CN 104994871B
- Authority
- CN
- China
- Prior art keywords
- fusion protein
- influenza
- protein
- cell
- vaccine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/145—Orthomyxoviridae, e.g. influenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55516—Proteins; Peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55544—Bacterial toxins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16211—Influenzavirus B, i.e. influenza B virus
- C12N2760/16234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Abstract
Description
Claims (3)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2013107777/10A RU2531235C2 (ru) | 2013-02-15 | 2013-02-15 | Поливалентная вакцина против гриппа на основе гибридного белка |
RU2013107777 | 2013-02-15 | ||
PCT/RU2014/000096 WO2014126510A2 (en) | 2013-02-15 | 2014-02-14 | Polyvalent fusion protein vaccine against influenza |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104994871A CN104994871A (zh) | 2015-10-21 |
CN104994871B true CN104994871B (zh) | 2018-01-26 |
Family
ID=51354649
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201480008848.7A Expired - Fee Related CN104994871B (zh) | 2013-02-15 | 2014-02-14 | 针对流感的多价融合蛋白疫苗 |
Country Status (11)
Country | Link |
---|---|
US (1) | US9480737B2 (zh) |
EP (1) | EP2956168B8 (zh) |
CN (1) | CN104994871B (zh) |
CU (1) | CU24288B1 (zh) |
EA (1) | EA027463B1 (zh) |
HK (1) | HK1216499A1 (zh) |
MX (1) | MX362420B (zh) |
NI (1) | NI201500109A (zh) |
RU (1) | RU2531235C2 (zh) |
UA (1) | UA115895C2 (zh) |
WO (1) | WO2014126510A2 (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2757013C2 (ru) * | 2017-12-19 | 2021-10-08 | Федеральное государственное бюджетное учреждение "Научно-исследовательский институт гриппа имени А.А. Смородинцева" Министерства здравоохранения Российской Федерации | Рекомбинантная противогриппозная вакцина с широким спектром защиты и способ ее получения |
AU2019238171A1 (en) | 2018-03-19 | 2020-09-24 | Novavax, Inc. | Multivalent influenza nanoparticle vaccines |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101394864A (zh) * | 2006-03-07 | 2009-03-25 | 法克斯因内特公司 | 包含血细胞凝集素的组合物、制造其的方法与使用其的方法 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL127331A0 (en) * | 1998-11-30 | 1999-09-22 | Yeda Res & Dev | Peptide-based vaccine for influenza |
CA2654178A1 (en) | 2006-06-16 | 2007-12-27 | Dow Agrosciences Llc | Novel dna sequences, vectors and proteins of avian influenza hemagglutinin |
RU2358981C2 (ru) * | 2007-08-07 | 2009-06-20 | Центр "Биоинженерия" Российской Академии Наук | Универсальная вакцина против вируса гриппа птиц |
RU2008139004A (ru) | 2008-10-01 | 2010-04-10 | Биологический факультет Московского государственного университета им. М.В. Ломоносова (RU) | Ген вакцинного искусственного белка, продуцирующий в растениях рекомбинантную мультиэпитопную вакцину на базе гемагглютинина вируса гриппа птиц |
CN101450209B (zh) | 2008-12-31 | 2012-01-25 | 中国人民解放军军事医学科学院微生物流行病研究所 | 透皮免疫流感多价疫苗的制备及其方法 |
JP2009102416A (ja) | 2009-02-04 | 2009-05-14 | Protein Sciences | インフルエンザ血球凝集素多価ワクチンの製造方法 |
CN101524538A (zh) | 2009-03-26 | 2009-09-09 | 成都康华生物制品有限公司 | 一种流感-大流行流感二价联合疫苗及其制备方法 |
EP2413962A1 (en) * | 2009-03-30 | 2012-02-08 | Mount Sinai School of Medicine | Influenza virus vaccines and uses thereof |
CN101732711A (zh) | 2009-12-31 | 2010-06-16 | 中国人民解放军军事医学科学院微生物流行病研究所 | 一种喷鼻免疫流感五价或多价灭活疫苗的制备及其应用 |
US8513006B2 (en) * | 2010-09-14 | 2013-08-20 | University of Pittsburgh—of the Commonwealth System of Higher Education | Tetravalent influenza vaccine and use thereof |
-
2013
- 2013-02-15 RU RU2013107777/10A patent/RU2531235C2/ru not_active IP Right Cessation
-
2014
- 2014-02-14 EA EA201500770A patent/EA027463B1/ru not_active IP Right Cessation
- 2014-02-14 WO PCT/RU2014/000096 patent/WO2014126510A2/en active Application Filing
- 2014-02-14 US US14/768,107 patent/US9480737B2/en active Active
- 2014-02-14 EP EP14751295.8A patent/EP2956168B8/en active Active
- 2014-02-14 CN CN201480008848.7A patent/CN104994871B/zh not_active Expired - Fee Related
- 2014-02-14 MX MX2015010623A patent/MX362420B/es active IP Right Grant
- 2014-02-14 UA UAA201508723A patent/UA115895C2/uk unknown
- 2014-02-14 CU CUP2015000083A patent/CU24288B1/xx unknown
-
2015
- 2015-08-14 NI NI201500109A patent/NI201500109A/es unknown
-
2016
- 2016-04-15 HK HK16104349.2A patent/HK1216499A1/zh not_active IP Right Cessation
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101394864A (zh) * | 2006-03-07 | 2009-03-25 | 法克斯因内特公司 | 包含血细胞凝集素的组合物、制造其的方法与使用其的方法 |
Non-Patent Citations (1)
Title |
---|
Superior efficacy of a recombinant flagellin:H5N1 HA globular head vaccine is determined by the placement of the globular head within flagellin;Langzhou Song et al.;《Vaccine》;20090925;第27卷(第42期);第5875–5884页 * |
Also Published As
Publication number | Publication date |
---|---|
US9480737B2 (en) | 2016-11-01 |
EA027463B1 (ru) | 2017-07-31 |
EP2956168A2 (en) | 2015-12-23 |
EP2956168A4 (en) | 2016-09-14 |
US20150374814A1 (en) | 2015-12-31 |
RU2531235C2 (ru) | 2014-10-20 |
MX2015010623A (es) | 2015-12-15 |
RU2013107777A (ru) | 2014-08-20 |
CN104994871A (zh) | 2015-10-21 |
EA201500770A1 (ru) | 2015-12-30 |
UA115895C2 (uk) | 2018-01-10 |
MX362420B (es) | 2019-01-14 |
HK1216499A1 (zh) | 2016-11-18 |
WO2014126510A2 (en) | 2014-08-21 |
EP2956168B1 (en) | 2018-07-25 |
WO2014126510A3 (en) | 2014-10-16 |
CU24288B1 (es) | 2017-12-08 |
EP2956168B8 (en) | 2019-01-23 |
NI201500109A (es) | 2015-10-27 |
CU20150083A7 (es) | 2016-07-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP7250878B2 (ja) | 新規多価ナノ粒子に基づくワクチン | |
CN105555306B (zh) | 免疫原性中东呼吸综合征冠状病毒(MERS-CoV)组合物和方法 | |
CN105263516A (zh) | 流感病毒疫苗及其用途 | |
KR20080081901A (ko) | 기능성 인플루엔자 바이러스 유사 입자들 | |
CN105906721B (zh) | 一种水痘-带状疱疹病毒gB-gE-gH-gL融合蛋白、基因工程亚单位疫苗及制备方法 | |
CN113201507B (zh) | 一种重组的伪狂犬病病毒及其疫苗组合物 | |
CN104470538B (zh) | 针对由肺炎链球菌引起的肺炎的嵌合蛋白疫苗 | |
CN117098553A (zh) | 多价载体和相关疫苗组合物 | |
CN107847579A (zh) | 人和禽h5n1流感的计算优化的广泛反应性抗原的协同共同给药 | |
Wei et al. | Biomedical applications of lumazine synthase | |
CN102816246B (zh) | 一种人巨细胞病毒免疫原融合蛋白及其制备方法和用途 | |
CN102181457B (zh) | 密码子优化的艰难梭菌外毒素b氨基端基因序列及其核酸疫苗 | |
CN104994871B (zh) | 针对流感的多价融合蛋白疫苗 | |
CN107530417A (zh) | H1n1流感的计算优化的广泛反应性抗原的协同共同给药 | |
WO2013102492A1 (en) | Synthetic genes encoding peptide fragments of natural myelin proteins for induction of oral tolerance, dna fragment comprising these genes, means of obtaining these peptides in a microbial (bacterial) system and their medical application | |
CN114634578A (zh) | 针对新型冠状病毒感染的疫苗组合物 | |
KR101908905B1 (ko) | 인플루엔자 바이러스의 h9 및 h5의 다중 아형에 대한 교차 면역반응을 형성하는 신규한 재조합 인플루엔자 바이러스 및 이를 포함하는 백신 | |
US20180251769A1 (en) | Recombinant Influenza Virus | |
RU2539913C2 (ru) | Вакцина для профилактики и лечения ротавирусной инфекции, содержащая гибридный белок в качестве активного агента (варианты) | |
CN104630172B (zh) | 一种血吸虫谷胱甘肽‑s‑转移酶的突变体及其应用 | |
CN113603793A (zh) | 一种新型冠状病毒的重组s蛋白、重组质粒、重组菌及制备外泌体药物或外泌体疫苗的应用 | |
Markushin | Investigation of Efficiency of Site-Specific Mutants of the Influenza Virus in Homological and Heterologi-cal Control Infection | |
EA037849B1 (ru) | Гибридный белок, днк, генетическая конструкция, продуцент, вакцина на основе гибридного белка для профилактики и лечения туберкулеза (варианты) | |
RU2560588C1 (ru) | СПОСОБ ПОЛУЧЕНИЯ ИММУНОГЕННОЙ КОМПОЗИЦИИ НА ОСНОВЕ ТРЕХ ГИБРИДНЫХ БЕЛКОВ ОБОЛОЧКИ ВИРУСА КЛЕЩЕВОГО ЭНЦЕФАЛИТА, ОПРЕДЕЛЯЮЩИХ ПРИНАДЛЕЖНОСТЬ К СИБИРСКОМУ (DBD2-D3S), ЕВРОПЕЙСКОМУ (DBD2-D3E) И ДАЛЬНЕВОСТОЧНОМУ (DBD2-D3D) ПОДТИПАМ ВИРУСА; РЕКОМБИНАНТНЫЕ ПЛАЗМИДЫ pDBD2-D3S, pDBD2-D3E И pDBD2-D3D; ШТАММЫ-ПРОДУЦЕНТЫ Escherichia coli M15 [pREP4]; ХИМЕРНЫЕ БЕЛКИ И ИХ ПРИМЕНЕНИЕ | |
US8691959B2 (en) | Plasmids with immunological action |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1216499 Country of ref document: HK |
|
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20180409 Address after: Russia St Petersburg Patentee after: ABS Co., Ltd. Address before: Russia, St Petersburg Patentee before: UNIVERSAL BIOSYSTEMS LTD COMPANY UBS LTD. |
|
REG | Reference to a national code |
Ref country code: HK Ref legal event code: GR Ref document number: 1216499 Country of ref document: HK |
|
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20180126 Termination date: 20210214 |